comparemela.com

Latest Breaking News On - Manufacturing services division - Page 1 : comparemela.com

Titan Company Ltd - Quarterly Update: Q4FY23

Titan Company Ltd has announced the quarterly operational update for the period ended March 31, 2023 i.e., Q4FY23.

United arab emiratesTaj mahalUttar pradeshWest bengalUnited statesAbu dhabiTitan engineering automation limitedTitan companyStatutory auditors of the companyManufacturing services divisionLarge format storesTitan company ltdAutomation solutions divisionTaj mahal palaceSilicon oasisUniform consumer price

Titan Reports 12 Growth In Combined Sales In Q3FY23

Titan Reports 12 Growth In Combined Sales In Q3FY23
businessworld.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessworld.in Daily Mail and Mail on Sunday newspapers.

United arab emiratesUnited statesNew jerseyAbu dhabiBhai doojManufacturing services divisionTitan engineering automation limitedAutomation solutions divisionLarge format storesEdge squircleRaga delightTitan worldFashion accessoriesIndian dress wearTitan engineeringAutomation limited

Titan Company Limited - Quarterly Update - Q3FY23

Titan Company Limited has announced the Quarterly Update on various businesses for the period ended December 31, 2022 i.e., Q3FY23.

United arab emiratesUnited statesNew jerseyTamil naduAbu dhabiBhai doojManufacturing services divisionTitan companyTitan engineering automation limitedAutomation solutions divisionStatutory auditors of the companyLarge format storesTitan company limitedEdge squircleTitan quartetRaga delight

With Covid gone as a money spinner, what are companies like Cipla, Sun Pharma and Dr Reddy s looking at?

There is also muted demand for the much-hyped anti-viral drug Molnupiravir, which at least 13 firms are manufacturing including Sun Pharma, Cipla, Dr. Reddy’s, and Aurobindo Pharma, among others.

Jonathan huntSun pharmaRajesh pherwaniUmang vohraAurobindo pharmaSyngene developmentSun pharmaceuticalsManufacturing services divisionSyngene internationalSerum institute of indiaSerum instituteBharat biotechRussian covidAurigene discovery technologiesPortfolio managerValcreate investment

Syngene stock zooms over 4% on signing 10-year biologics manufacturing agreement with Zoetis

This agreement, initially centred on Librela, paves the way for development and manufacturing of other molecules in the coming years.

United kingdomJonathan huntNick ashtonManufacturing organisationContract developmentManufacturing services divisionZoetis incSyngene internationalSyngene international limitedChief executive officerExecutive vice presidentGlobal manufacturing

vimarsana © 2020. All Rights Reserved.